Cormorant Asset Management, LP Diversified Active

CIK: 0001583977 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Nov 14, 2014

Total Value ($000): $486,175 (100.0% shares, 0.0% debt)

Holdings (65)

PBYI PUMA BIOTECHNOLOGY INC 24.9%
Value ($000) $121,074 Shares 507,500 Est. Cost $146.25 Unrealized +40.4%
RECEPTOS INC 9.6%
Value ($000) $46,502 Shares 748,700 Est. Cost $43.18 Unrealized
JAZZ JAZZ PHARMACEUTICALS PLC 3.3%
Value ($000) $16,056 Shares 100,000 Est. Cost $150.52 Unrealized +2.1%
DYAX CORP 3.1%
Value ($000) $15,180 Shares 1,500,000 Est. Cost $7.54 Unrealized
KERYX BIOPHARMACEUTICALS 2.8%
Value ($000) $13,750 Shares 1,000,000 Est. Cost $13.75 Unrealized
KARYOPHARM THERAPEUTICS INC 2.8%
Value ($000) $13,452 Shares 385,000 Est. Cost $33.09 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 2.7%
Value ($000) $13,320 Shares 850,000 Est. Cost $14.65 Unrealized +2.0%
ARROWHEAD RESH CORP 2.7%
Value ($000) $13,293 Shares 900,000 Est. Cost $10.85 Unrealized
ACCELERON PHARMA INC 2.5%
Value ($000) $12,096 Shares 400,000 Est. Cost $32.10 Unrealized
BCRX BIOCRYST PHARMACEUTICALS INC 2.2%
Value ($000) $10,758 Shares 1,100,000 Est. Cost $9.67 Unrealized +26.8%
AKBA AKEBIA THERAPEUTICS INC 1.8%
Value ($000) $8,852 Shares 400,000 Est. Cost $24.08 Unrealized -4.6%
OVASCIENCE INC 1.8%
Value ($000) $8,569 Shares 516,200 Est. Cost $16.60 Unrealized
TESARO INC 1.7%
Value ($000) $8,076 Shares 300,000 Est. Cost $28.24 Unrealized
DXCM DEXCOM INC 1.6%
Value ($000) $7,998 Shares 200,000 Est. Cost $7.91 Unrealized +29.2%
BMY BRISTOL MYERS SQUIBB CO 1.6%
Value ($000) $7,677 Shares 150,000 Est. Cost $34.21 Unrealized 0.0%
OMER OMEROS CORP 1.4%
Value ($000) $6,969 Shares 547,900 Est. Cost $12.47 Unrealized +12.3%
CHIMERIX INC 1.4%
Value ($000) $6,905 Shares 250,000 Est. Cost $19.16 Unrealized
SYNAGEVA BIOPHARMA CORP 1.4%
Value ($000) $6,878 Shares 100,000 Est. Cost $68.78 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL INC 1.4%
Value ($000) $6,792 Shares 120,000 Est. Cost $46.32 Unrealized +8.6%
NOVAVAX INC 1.3%
Value ($000) $6,255 Shares 1,500,000 Est. Cost $4.95 Unrealized
AGIO AGIOS PHARMACEUTICALS INC 1.3%
Value ($000) $6,135 Shares 100,000 Est. Cost $43.10 Unrealized 0.0%
HRTX HERON THERAPEUTICS INC 1.2%
Value ($000) $5,831 Shares 700,000 Est. Cost $11.95 Unrealized -22.0%
ARDX ARDELYX INC 1.1%
Value ($000) $5,523 Shares 388,700 Est. Cost $14.46 Unrealized 0.0%
PTCT PTC THERAPEUTICS INC 1.1%
Value ($000) $5,501 Shares 125,000 Est. Cost $26.39 Unrealized +18.6%
ACELRX PHARMACEUTICALS INC 1.1%
Value ($000) $5,490 Shares 1,000,000 Est. Cost $9.56 Unrealized
NEKTAR THERAPEUTICS 1.1%
Value ($000) $5,432 Shares 450,000 Est. Cost $12.07 Unrealized
SGMO SANGAMO BIOSCIENCES INC 1.1%
Value ($000) $5,393 Shares 500,000 Est. Cost $17.13 Unrealized -23.7%
CHINA BIOLOGIC PRODS INC 1.1%
Value ($000) $5,126 Shares 95,000 Est. Cost $44.47 Unrealized
EGRX EAGLE PHARMACEUTICALS INC 1.0%
Value ($000) $5,060 Shares 400,000 Est. Cost $13.58 Unrealized -8.7%
PORTOLA PHARMACEUTICALS INC 1.0%
Value ($000) $5,056 Shares 200,000 Est. Cost $25.84 Unrealized
QUOTIENT LTD 1.0%
Value ($000) $4,715 Shares 500,000 Est. Cost $8.36 Unrealized
SRNE SORRENTO THERAPEUTICS INC 0.9%
Value ($000) $4,520 Shares 1,000,000 Est. Cost $10.01 Unrealized -46.3%
ALKS ALKERMES PLC 0.9%
Value ($000) $4,287 Shares 100,000 Est. Cost $47.58 Unrealized -5.8%
ALNY ALNYLAM PHARMACEUTICALS INC 0.8%
Value ($000) $3,905 Shares 50,000 Est. Cost $59.65 Unrealized +8.1%
VERSARTIS INC 0.8%
Value ($000) $3,798 Shares 200,000 Est. Cost $28.04 Unrealized
ROCKWELL MED INC 0.8%
Value ($000) $3,656 Shares 400,000 Est. Cost $12.66 Unrealized
ARRAY BIOPHARMA INC 0.7%
Value ($000) $3,570 Shares 1,000,000 Est. Cost $5.01 Unrealized
IMMUNE DESIGN CORP 0.7%
Value ($000) $3,532 Shares 200,000 Est. Cost $17.66 Unrealized
NANOSTRING TECHNOLOGIES INC 0.7%
Value ($000) $3,282 Shares 300,000 Est. Cost $20.65 Unrealized
GLYCOMIMETICS INC 0.7%
Value ($000) $3,278 Shares 472,300 Est. Cost $16.33 Unrealized
KINDRED BIOSCIENCES INC 0.7%
Value ($000) $3,238 Shares 350,000 Est. Cost $11.93 Unrealized
CLOVIS ONCOLOGY INC 0.7%
Value ($000) $3,175 Shares 70,000 Est. Cost $60.27 Unrealized
KITE PHARMA INC 0.6%
Value ($000) $2,850 Shares 100,000 Est. Cost $28.50 Unrealized
GENVEC INC 0.6%
Value ($000) $2,765 Shares 1,329,300 Est. Cost $2.65 Unrealized
AUSPEX PHARMACEUTICALS INC 0.5%
Value ($000) $2,567 Shares 100,000 Est. Cost $30.76 Unrealized
GALT GALECTIN THERAPEUTICS INC 0.5%
Value ($000) $2,266 Shares 450,400 Est. Cost $13.23 Unrealized -41.1%
AVALANCHE BIOTECHNOLOGIES IN 0.5%
Value ($000) $2,222 Shares 65,000 Est. Cost $34.18 Unrealized
RECRO PHARMA INC 0.4%
Value ($000) $2,072 Shares 700,000 Est. Cost $6.07 Unrealized
AGENUS INC 0.4%
Value ($000) $2,022 Shares 650,000 Est. Cost $3.17 Unrealized
AQUINOX PHARMACEUTICALS INC 0.4%
Value ($000) $1,998 Shares 300,000 Est. Cost $12.15 Unrealized
ZS PHARMA INC 0.4%
Value ($000) $1,962 Shares 50,000 Est. Cost $39.24 Unrealized
ALDER BIOPHARMACEUTICALS INC 0.4%
Value ($000) $1,902 Shares 150,000 Est. Cost $20.07 Unrealized
CERULEAN PHARMA INC 0.4%
Value ($000) $1,899 Shares 450,000 Est. Cost $5.80 Unrealized
CELSUS THERAPEUTICS PLC 0.3%
Value ($000) $1,491 Shares 244,500 Est. Cost $6.26 Unrealized
REGULUS THERAPEUTICS INC 0.3%
Value ($000) $1,366 Shares 200,000 Est. Cost $8.21 Unrealized
CELLECTAR BIOSCIENCES INC 0.2%
Value ($000) $1,177 Shares 530,000 Est. Cost $2.22 Unrealized
ADVAXIS INC 0.2%
Value ($000) $1,176 Shares 350,000 Est. Cost $3.36 Unrealized
APPLIED GENETIC TECHNOL CORP 0.2%
Value ($000) $1,128 Shares 60,600 Est. Cost $23.10 Unrealized
AGILE THERAPEUTICS INC 0.2%
Value ($000) $1,095 Shares 150,000 Est. Cost $8.72 Unrealized
MINERVA NEUROSCIENCES INC 0.2%
Value ($000) $1,059 Shares 175,000 Est. Cost $6.05 Unrealized
BRISTOL MYERS SQUIBB CO 0.2%
Value ($000) $985 Shares 5,000 Est. Cost $197.00 Unrealized
CURIS INC 0.2%
Value ($000) $846 Shares 600,000 Est. Cost $1.86 Unrealized
SCYNEXIS INC 0.2%
Value ($000) $739 Shares 100,000 Est. Cost $8.02 Unrealized
CELLECTAR BIOSCIENCES INC 0.1%
Value ($000) $318 Shares 530,000 Est. Cost $0.60 Unrealized
SAGE THERAPEUTICS INC 0.1%
Value ($000) $315 Shares 10,000 Est. Cost $31.50 Unrealized